Abeeb Oyelere - Search Results

Year	Number of Results
1996	1
1999	1
2001	2
2002	1
2003	2
2006	1
2007	2
2008	5
2009	4
2010	6
2012	5
2013	5
2014	3
2015	5
2016	2
2017	4
2018	4
2019	7
2020	11
2021	13
2022	14
2023	12
2024	5

1

Macrocycles in medicinal chemistry and drug discovery.

Oyelere AK. Oyelere AK. Curr Top Med Chem. 2010;10(14):1359-60. doi: 10.2174/156802610792232097. Curr Top Med Chem. 2010. PMID: 20919989 No abstract available.

2

Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges.

Wu B, Sodji QH, Oyelere AK. Wu B, et al. Cancers (Basel). 2022 Jan 22;14(3):552. doi: 10.3390/cancers14030552. Cancers (Basel). 2022. PMID: 35158821 Free PMC article. Review.

3

Macrocyclic histone deacetylase inhibitors.

Mwakwari SC, Patil V, Guerrant W, Oyelere AK. Mwakwari SC, et al. Curr Top Med Chem. 2010;10(14):1423-40. doi: 10.2174/156802610792232079. Curr Top Med Chem. 2010. PMID: 20536416 Free PMC article. Review.

4

Unveiling the dark side of glucose-regulated protein 78 (GRP78) in cancers and other human pathology: a systematic review.

Akinyemi AO, Simpson KE, Oyelere SF, Nur M, Ngule CM, Owoyemi BCD, Ayarick VA, Oyelami FF, Obaleye O, Esoe DP, Liu X, Li Z. Akinyemi AO, et al. Mol Med. 2023 Aug 21;29(1):112. doi: 10.1186/s10020-023-00706-6. Mol Med. 2023. PMID: 37605113 Free PMC article. Review.

5

A detailed review on the phytochemical profiles and anti-diabetic mechanisms of Momordica charantia.

Oyelere SF, Ajayi OH, Ayoade TE, Santana Pereira GB, Dayo Owoyemi BC, Ilesanmi AO, Akinyemi OA. Oyelere SF, et al. Heliyon. 2022 Apr 6;8(4):e09253. doi: 10.1016/j.heliyon.2022.e09253. eCollection 2022 Apr. Heliyon. 2022. PMID: 35434401 Free PMC article. Review.

6

Virtual Reality for Addressing Depression and Anxiety: A Bibliometric Analysis.

Jingili N, Oyelere SS, Ojwang F, Agbo FJ, Nyström MBT. Jingili N, et al. Int J Environ Res Public Health. 2023 Apr 24;20(9):5621. doi: 10.3390/ijerph20095621. Int J Environ Res Public Health. 2023. PMID: 37174141 Free PMC article. Review.

7

Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed.

Gryder BE, Sodji QH, Oyelere AK. Gryder BE, et al. Future Med Chem. 2012 Mar;4(4):505-24. doi: 10.4155/fmc.12.3. Future Med Chem. 2012. PMID: 22416777 Free PMC article. Review.

8

Targeting the mitochondrial permeability transition pore for drug discovery: Challenges and opportunities.

Boyenle ID, Oyedele AK, Ogunlana AT, Adeyemo AF, Oyelere FS, Akinola OB, Adelusi TI, Ehigie LO, Ehigie AF. Boyenle ID, et al. Mitochondrion. 2022 Mar;63:57-71. doi: 10.1016/j.mito.2022.01.006. Epub 2022 Jan 22. Mitochondrion. 2022. PMID: 35077882 Review.

9

TBK1 regulates regeneration of pancreatic β-cells.

Jia YF, Jeeva S, Xu J, Heppelmann CJ, Jang JS, Slama MQ, Tapadar S, Oyelere AK, Kang SM, Matveyenko AV, Peterson QP, Shin CH. Jia YF, et al. Sci Rep. 2020 Nov 9;10(1):19374. doi: 10.1038/s41598-020-76600-6. Sci Rep. 2020. PMID: 33168920 Free PMC article.

10

Discovery of novel STAT3 DNA binding domain inhibitors.

Wu B, Payero B, Taylor S, Oyelere AK. Wu B, et al. Future Med Chem. 2021 Aug;13(15):1253-1269. doi: 10.4155/fmc-2021-0088. Epub 2021 Jun 28. Future Med Chem. 2021. PMID: 34180263

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

103 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year